6th April 2020
Polar Capital Global Healthcare Trust plc (the "Company")
Top Ten Equity Holdings and Sector and Geographic Exposure as at 31st March 2020 and full portfolio listing as at 28th February 2020 available from the company's website
Polar Capital Global Healthcare Trust plc is pleased to announce that as at 28th February 2020 the top ten equity holdings and the sector and geographic breakdown were as follows:
Top 10 Holdings |
% |
Roche |
6.4% |
Bristol Myers Squibb |
5.1% |
Novo Nordisk A/S |
4.8% |
Merck & Co |
4.7% |
AbbVie |
4.4% |
Sanofi |
4.1% |
Bio-Rad Laboratories |
3.9% |
Becton Dickinson |
3.9% |
Fresenius Medical Care AG & Co |
3.8% |
Centene Corp |
3.6% |
Total |
44.7% |
Sector Exposure |
% |
Pharmaceuticals |
35.5% |
Biotechnology |
22.9% |
Healthcare Equipment |
18.2% |
Life Sciences Tools & Services |
11.3% |
Managed Healthcare |
7.7% |
Healthcare Services |
7.2% |
Healthcare Facilities |
3.1% |
Healthcare Technology |
1.9% |
Healthcare Supplies |
1.2% |
Healthcare Distributors |
0.9% |
Cash |
-9.8% |
Total |
100.0% |
Geographic Exposure |
% |
United States |
73.5% |
Denmark |
8.6% |
Switzerland |
6.4% |
France |
4.1% |
Germany |
3.8% |
Spain |
3.1% |
Belgium |
3.1% |
United Kingdom |
2.8% |
Japan |
2.0% |
Canada |
1.8% |
Netherlands |
0.7% |
Cash |
-9.8% |
Total |
100.0% |
Gearing Ratio as calculated in accordance with the guidelines of the Association of Investment Companies, was 10.2%. Gearing is made up of structural debt provided by the subsidiary company PCGH ZDP plc, through the issue of zero dividend preference shares.
The monthly factsheet will usually be available on the Company's website on the 10th working day after the month end and includes a commentary by the investment manager. www.Polarcapitalhealthcaretrust.co m
Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement .